These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10622182)

  • 21. Increased PKC activity and altered GSK3β/NMDAR function drive behavior cycling in HINT1-deficient mice: bipolarity or opposing forces.
    Garzón-Niño J; Rodríguez-Muñoz M; Cortés-Montero E; Sánchez-Blázquez P
    Sci Rep; 2017 Feb; 7():43468. PubMed ID: 28240305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.
    Watson DG; Watterson JM; Lenox RH
    J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?
    Manji HK; Moore GJ; Chen G
    Biol Psychiatry; 1999 Oct; 46(7):929-40. PubMed ID: 10509176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania.
    Abrial E; Bétourné A; Etiévant A; Lucas G; Scarna H; Lambás-Señas L; Haddjeri N
    Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25577667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurobiology of lithium: an update.
    Lenox RH; McNamara RK; Papke RL; Manji HK
    J Clin Psychiatry; 1998; 59 Suppl 6():37-47. PubMed ID: 9674936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lithium decreases membrane-associated protein kinase C in hippocampus: selectivity for the alpha isozyme.
    Manji HK; Etcheberrigaray R; Chen G; Olds JL
    J Neurochem; 1993 Dec; 61(6):2303-10. PubMed ID: 8245981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Possible involvement of protein kinase C in the pathophysiology and treatment of bipolar disorder].
    Einat H; Chen G; Manji H
    Harefuah; 2004 Jun; 143(6):420-5, 462. PubMed ID: 15524099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mood stabilizers: protecting the mood...protecting the brain.
    Brunello N
    J Affect Disord; 2004 Apr; 79 Suppl 1():S15-20. PubMed ID: 15121343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mood stabilizers regulate cytoprotective and mRNA-binding proteins in the brain: long-term effects on cell survival and transcript stability.
    Chen G; Huang LD; Zeng WZ; K Manji H
    Int J Neuropsychopharmacol; 2001 Mar; 4(1):47-64. PubMed ID: 11343630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased protein kinase C (PKC) in platelets of pediatric bipolar patients: effect of treatment with mood stabilizing drugs.
    Pandey GN; Ren X; Dwivedi Y; Pavuluri MN
    J Psychiatr Res; 2008 Jan; 42(2):106-16. PubMed ID: 17208254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of the mechanism of action of lithium in the brain: fifty-year update.
    Lenox RH; Hahn CG
    J Clin Psychiatry; 2000; 61 Suppl 9():5-15. PubMed ID: 10826655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation.
    Einat H; Yuan P; Gould TD; Li J; Du J; Zhang L; Manji HK; Chen G
    J Neurosci; 2003 Aug; 23(19):7311-6. PubMed ID: 12917364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium and tamoxifen modulate cellular plasticity cascades in animal model of mania.
    Cechinel-Recco K; Valvassori SS; Varela RB; Resende WR; Arent CO; Vitto MF; Luz G; de Souza CT; Quevedo J
    J Psychopharmacol; 2012 Dec; 26(12):1594-604. PubMed ID: 23076832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproate and neuroprotective effects for bipolar disorder.
    Atmaca M
    Int Rev Psychiatry; 2009; 21(4):410-3. PubMed ID: 20374154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signal transduction pathways. Molecular targets for lithium's actions.
    Manji HK; Potter WZ; Lenox RH
    Arch Gen Psychiatry; 1995 Jul; 52(7):531-43. PubMed ID: 7598629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder.
    McQuillin A; Rizig M; Gurling HM
    Pharmacogenet Genomics; 2007 Aug; 17(8):605-17. PubMed ID: 17622937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain.
    Valvassori SS; Dal-Pont GC; Resende WR; Jornada LK; Peterle BR; Machado AG; Farias HR; de Souza CT; Carvalho AF; Quevedo J
    Neuropharmacology; 2017 May; 117():447-459. PubMed ID: 27789311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of glycogen synthase kinase-3 in patients with affective disorders.
    O'Brien WT; Klein PS
    Biol Psychiatry; 2007 Jan; 61(2):139-41. PubMed ID: 17223440
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients.
    Wang HY; Markowitz P; Levinson D; Undie AS; Friedman E
    J Psychiatr Res; 1999; 33(2):171-9. PubMed ID: 10221749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.